NCT04944927

Brief Summary

Alternating Hemiplegia of Childhood (AHC) is a rare and severe disease that is in need of effective, and hopefully even curative, therapies. Afflicted patients suffer from severe paralyzing crises, often excruciatingly painful muscle spasms, severe often life threatening epileptic seizures, frequently severe developmental and psychiatric/psychological disabilities and other comorbidities, such as cardiac disturbances. Recent data indicate that AHC genotype is in relation to cardiac repolarization troubles and to cardiac arrhythmias. The primary hypothesis to explore is that there is an association between genotype and cardiac phenotype in AHC.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Apr 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 29, 2021

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

June 2, 2021

Completed
28 days until next milestone

First Posted

Study publicly available on registry

June 30, 2021

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 29, 2021

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 29, 2022

Completed
Last Updated

February 22, 2023

Status Verified

February 1, 2023

Enrollment Period

8 months

First QC Date

June 2, 2021

Last Update Submit

February 20, 2023

Conditions

Keywords

QTcCardiac repolarization and arrhythmiaECGAlternating Hemiplegia

Outcome Measures

Primary Outcomes (1)

  • Measurement of QTc interval and all relevant cardiac repolarization measurements

    Outcome measure: QTc interval and cardiac repolarization measurement in milliseconds.

    Day 1

Study Arms (1)

Patients with Alternating Hemiplegia of Childhood

Patients that meet the clinical diagnostic criteria (Aicardi et al, 1995) for typical alternating hemiplegia with or without identified mutations in ATP1A3. At least one prolonged ECG study available is required.

Other: Recording of clinical parameters and electrocardiogram parameters

Interventions

Retrospective recording of demographic information (age, sex, age at diagnosis), genetic information, cardiological information, pharmacological treatments, electrocardiogram data. All above data will be deidentified.

Patients with Alternating Hemiplegia of Childhood

Eligibility Criteria

Age12 Months+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with Alternating Hemiplegia of Childhood

You may qualify if:

  • Patients that meet the clinical diagnostic criteria (Aicardi et al, 1995) for typical alternating hemiplegia with or without identified mutations in ATP1A3.
  • At least one ECG study is required.
  • Patients ages yearand more

You may not qualify if:

  • Informed consent or assent not obtainable
  • ATP1A3 testing not performed
  • No ECG studies are available

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Clinical Epileptology, Sleep Disorders and Functional Neurology in Children, Hôpital Femme Mère Enfant, University Hospitals of Lyon (Hospices Civils de Lyon)

Bron, 69677, France

Location

MeSH Terms

Conditions

Alternating hemiplegia of childhoodArrhythmias, Cardiac

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 2, 2021

First Posted

June 30, 2021

Study Start

April 29, 2021

Primary Completion

December 29, 2021

Study Completion

June 29, 2022

Last Updated

February 22, 2023

Record last verified: 2023-02

Locations